Nanomerics is a leading brand in Molecular Engineered Materials, utilizing its innovative Molecular Envelope Technology platform to create groundbreaking medicines. By enhancing drug efficacy, specificity, and safety, Nanomerics is revolutionizing drug delivery technology. Based in London, UK, Nanomerics is a privately held specialty pharmaceutics company dedicated to the development of superior medicines.

Their focus is on reducing typical development costs, resources, and timelines, ultimately improving patient outcomes. Nanomerics boasts an impressive pipeline of both its own programs and partnered initiatives, addressing critical medical needs such as non-addictive pain therapies, degenerative CNS conditions, and treatments to preserve eye sight. They also prioritize advancements in oral medications and aim to minimize the risk of viral infections, including Sars-Cov2.

Utilizing their proprietary technology, Nanomerics enhances and repurposes existing drugs and new chemical entities, making them more effective. Their Molecular Masks, like the nasal spray, minimize the risk of viral infections. Nanomerics' expertise lies in molecular engineered materials, allowing for advanced drug delivery and biomaterials.

The Molecular Envelope Technology (MET) platform, in particular, significantly improves drug delivery and leads to superior medicines with enhanced efficacy and reduced side effects